Skip to content

7-DAY VERSUS 10-DAY INTRAVENOUS ANTIBIOTICS FOR NEONATAL SEPSIS: A RANDOMIZED CONTROLLED TRIAL

7-DAY VERSUS 10-DAY INTRAVENOUS ANTIBIOTICS FOR NEONATAL SEPSIS: A RANDOMIZED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/01/003302
Enrollment
80
Registered
2013-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A499- Bacterial infection, unspecified Health Condition 2: null- Neonatal septicemia

Interventions

Intervention1: Antibiotic: Duration 7 days Intervention2: Antibiotic: For 7 days duration
dose adjusted for babys weight Ceftriaxone: 50 mg/kg/day, once daily Amikacin, 7.5 mg/kg/dose, twice daily Vancomycin: 10 mg/kg/dose QID Meropenem: 20 mg/kg/dose, twice daily Control Intervention1: An
Dose according to babys weight Amikacin, 7.5 mg/kg/dose, twice daily Vancomycin: 10 mg/kg/dose QID Meropenem: 20 mg/kg/dose, twice daily

Sponsors

University College of Medical Sciences and Guru Teg Bahadur Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates delivered at �32 weeks gestation (according to modified Ballard scoring and a birth weight �1.5kg,with symptomatic culture positive sepsis.Both early and late onset neonatal sepsis will be included in the study.

Exclusion criteria

Exclusion criteria: Deep seated infections-meningitis, osteomyelitis,septic arthritis Severe birth asphyxia (1 minute Apgar score � 3) Gross congenital anomalies Symptoms persisting (non-remittance) after 5 days of antibiotic therapy Fungal sepsis Neonates residing outside 15 kms radius of GTB Hospital,Delhi. Neonates requiring central line Neonates requiring exchange transfusion Neonates on mechanical ventilation.

Design outcomes

Primary

MeasureTime frame
Treatment failure: Defined by the reappearance of signs and symptoms of sepsis within 28 days of stopping antibiotics, supported by the presence of a positive blood culture growing the same organism as cultured earlier (according to the similar antibiogram as obtained previously or strain typing by pulse field gel electrophoresis where possible), OR in the absence of a positive culture, the presence of reactive CRP and as adjudicated by an expert committee.Timepoint: Within first 28 days of stopping antibiotics

Secondary

MeasureTime frame
To correlate treatment failure in both groups with: ïâ??§ Positive C-reactive protein on day 7 of antibiotic therapy ïâ??§ The type of pathogen isolated ïâ??§ Duration of hospital stay 2. To see if the pathogen implicated in relapse correlates with the pathogen isolated in the stool culture/rectal swab on the day of discharge. Timepoint: 7 days; within 28 days of discharge

Countries

India

Contacts

Public ContactPooja Dewan
rohatgi.smriti@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026